Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small molecules targeting ARF1 interaction with C9orf72:SMCR8:WDR41 complexes suppress its overactivation implicated in ALS/FTD.

bioRxiv : the preprint server for biology·2026
Same author

A careful examination of large behavior models for multitask dexterous manipulation.

Science robotics·2026
Same author

American Urological Association-symptom Index Lacks Internal Consistency for Measuring Storage Voiding Symptoms.

Urology·2026
Same author

Teachers' perspectives on barriers and motivators to physical activity participation in children from ethnic minority groups in Newcastle upon Tyne: A qualitative study.

PloS one·2026
Same author

Quantifying the effect of Behaviour Self-Regulation on well-being through causal analysis: A methodological framework for longitudinal health data.

Journal of biomedical informatics·2026
Same author

Home intravenous antibiotics for cystic fibrosis - setting up a hospital @home service.

Paediatric respiratory reviews·2025

Related Experiment Video

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Technology and Dementia Preconference.

Emma Dixon1, Elizabeth Gilman1, Kandianos Emmanouil Sakalidis2

  • 1Clemson University, Clemson, SC, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary

Individuals with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early dementia are exploring AI tools for workplace support. However, current tools lack adjustability, sometimes causing self-consciousness and tool abandonment.

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Area of Science:

  • Cognitive Science
  • Human-Computer Interaction
  • Occupational Health

Background:

  • Individuals with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early-onset dementia risk job loss.
  • Workplace accommodations are crucial but can be challenging.
  • Digital accommodations offer potential support for this population.

Purpose of the Study:

  • To understand the experiences of individuals with SCD, MCI, or early-onset dementia in the workplace.
  • To identify tools utilized by these individuals to maintain employment.
  • To explore opportunities for digital accommodations.

Main Methods:

  • Two rounds of semi-structured interviews with 11 participants.
  • Exploration of declarative knowledge, procedural skills, and work strategies.
  • Analysis of task flows and desired assistive technology support.
  • Reflexive thematic analysis of transcribed interviews.

Main Results:

  • Participants work in diverse roles and industries.
  • Eagerness to use emerging AI tools for accommodation was observed.
  • Lack of in-the-moment adjustability in AI tools was a key challenge.
  • AI tool usage can reveal cognitive changes, leading to self-consciousness and abandonment.

Conclusions:

  • People with cognitive changes are proactive in finding technological solutions for work.
  • Existing digital tools require modification for better usability.
  • The personal impact of adopting emerging AI tools needs further consideration.